Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmaceutical Mktg (PMRX) -- Ignore unavailable to you. Want to Upgrade?

To: Paul Lee who wrote (1)	3/12/1998 8:21:00 PM
From: Karl Drobnic	Read Replies (1) \| Respond to of 11

I've been following PMRX for the past couple years. It looks to me like they emerge from the makeover with cash and NDC share worth about $10/PMRX share, and a whole lot more if NDC shares go back to their previous highs. With a profitable operating qtr. just reported, PMRX has been selling at its cash value until the little run up this week. Even now, your $12 is getting $10 in cash and the rest of the company for $2 and change.